SSYS News & Events

Stratasys announced that its TrueDent resins have received CE marking as a Class IIa medical device, making them Europe's first high-esthetic, monolithic 3D-printed denture solution to achieve certification in the more than $2B market. The company said, "This milestone enables broader regulated clinical use and expands patient access to polychromatic, monolithic 3D-printed dentures, removable partial dentures, and crowns and bridges. The expanded indication now includes intraoral removables for long-term use of more than 30 days as well as crowns and bridges."

Sees FY26 revenue $565M-$575M, consensus $565.62M. Sees FY26 adjusted EBITDA $25M-$30M. Sees FY26 operating expenses $260M-$262M. Sees FY26 capital expenditures $20M-$25M. Zeif continued, "As we enter 2026, we do so with proven operational excellence, strategic clarity, and the technology portfolio to capitalize on the inevitable return of customer spending. Our commitment to innovation remains unwavering, supported by continued R&D investment and strategic partnerships that provide complete end-to-end solutions. Combined with our strong balance sheet, this positions us to capitalize on inorganic opportunities that we continue to explore, to sustain our technology leadership through strategic investments that will define the next era of digital manufacturing. The stage is set for sustained growth, as customers achieve measurable operational improvements and increase their utilization in true production-scale manufacturing for mission-critical applications."

Reports Q4 revenue $140M, consensus $139.32M. Yoav Zeif, Stratasys' CEO, stated, "Our fourth quarter performance caps a year in which we successfully maintained our operational discipline and delivered solid cash flow generation, demonstrating the resilience that distinguishes Stratasys. We generated 37.5% of our revenues from manufacturing applications, up from 25% in 2020, and made meaningful progress building on the foundational infrastructure of our highest-value use-cases, as we continued to improve our position in aerospace and defense, automotive tooling, dental, and medical applications."